These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

823 related items for PubMed ID: 19059448

  • 1. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
    Lee HY, Kim DJ, Lee HJ, Choi JE, Kim YK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):276-80. PubMed ID: 19059448
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK, Zalar B, Breskvar K, Dolzan V.
    J Psychopharmacol; 2006 Nov 17; 20(6):829-33. PubMed ID: 16478753
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association between the serotonin transporter gene (5-HTTLPR) and anger-related traits in Korean schizophrenic patients.
    Kim YR, Jahng JW, Min SK.
    Neuropsychobiology; 2009 Nov 17; 59(3):165-71. PubMed ID: 19439997
    [Abstract] [Full Text] [Related]

  • 6. Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population.
    Kim W, Choi YH, Yoon KS, Cho DY, Pae CU, Woo JM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec 30; 30(8):1413-8. PubMed ID: 16822601
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: a preliminary study.
    Yasui-Furukori N, Saito M, Nakagami T, Kaneda A, Tateishi T, Kaneko S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar 30; 30(2):286-91. PubMed ID: 16386826
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serotonin transporter polymorphisms and early response to antipsychotic treatment in first episode of psychosis.
    Vázquez-Bourgon J, Arranz MJ, Mata I, Pelayo-Terán JM, Pérez-Iglesias R, Medina-González L, Carrasco-Marín E, Vázquez-Barquero JL, Crespo-Facorro B.
    Psychiatry Res; 2010 Feb 28; 175(3):189-94. PubMed ID: 20031235
    [Abstract] [Full Text] [Related]

  • 11. [Lack of association between the insertion/deletion polymorphism in the serotonin transporter gene and schizophrenia].
    Kapelski P, Hauser J, Dmitrzak-Weglarz M, Skibińska M, Słopień A, Kaczmarkiewicz-Fass M, Rajewska A, Gattner K, Czerski PM.
    Psychiatr Pol; 2006 Feb 28; 40(5):925-35. PubMed ID: 17217236
    [Abstract] [Full Text] [Related]

  • 12. HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation.
    Bosia M, Anselmetti S, Pirovano A, Ermoli E, Marino E, Bramanti P, Smeraldi E, Cavallaro R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):81-5. PubMed ID: 19818823
    [Abstract] [Full Text] [Related]

  • 13. [Association of functional genes polymorphisms of key enzymes in the metabolism of biogenic amines with paranoid schizophrenia susceptibility and the influence of these polymorphisms on PANSS results in antipsychotic treatment].
    Tybura P, Grzywacz A, Syrek S, Parus M, Samochowiec J.
    Psychiatr Pol; 2006 Feb 01; 40(5):913-23. PubMed ID: 17217235
    [Abstract] [Full Text] [Related]

  • 14. Response of risperidone treatment may be associated with polymorphisms of HTT gene in Chinese schizophrenia patients.
    Wang L, Yu L, He G, Zhang J, Zhang AP, Du J, Tang RQ, Zhao XZ, Ma J, Xuan JK, Xiao Y, Gu NF, Feng GY, Xu MQ, Xing QH, He L.
    Neurosci Lett; 2007 Feb 27; 414(1):1-4. PubMed ID: 17287080
    [Abstract] [Full Text] [Related]

  • 15. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.
    Hamdani N, Tabeze JP, Ramoz N, Ades J, Hamon M, Sarfati Y, Boni C, Gorwood P.
    Eur Neuropsychopharmacol; 2008 Jan 27; 18(1):34-40. PubMed ID: 17669634
    [Abstract] [Full Text] [Related]

  • 16. No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.
    Zhang ZJ, Yao ZJ, Zhang XB, Chen JF, Sun J, Yao H, Hou G, Zhang XB.
    Acta Pharmacol Sin; 2003 Mar 27; 24(3):235-40. PubMed ID: 12617772
    [Abstract] [Full Text] [Related]

  • 17. Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia.
    Kaiser R, Tremblay PB, Schmider J, Henneken M, Dettling M, Müller-Oerlinghausen B, Uebelhack R, Roots I, Brockmöller J.
    Mol Psychiatry; 2001 Mar 27; 6(2):179-85. PubMed ID: 11317220
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.